Almost all of the research in NICR is officially classified as world-leading or internationally excellent in terms of originality, significance and rigour, having most of its evidence assessed as being in the highest categories of 4* and 3* for quality in the 2008 Research Assessment Exercise.
"Uniquely, we are one of two academic centres in the UK with the ability to undertake research of this type.
In clinical research, strong links exist between clinical staff, both ward and laboratory- based, and basic scientists, which enable fast and effective translation of clinical findings and speeds up the transition of new drugs from ‘bench to bedside’".
There are 4 interrelated research teams based in NICR:
Each research group coordinate their areas of expertise to:
It is only by combining our full range of laboratory and clinical disciplines needed to undertake research in contemporary experimental cancer medicine that advances in the development of personalised novel targeted therapies can be achieved.
In order to undertake our research it is essential that we have access to samples from patients with cancer or leukaemia. We store the samples we need in a variety of "Biobanks". Further details can be found about these biobank collections.
Figure shows organisation of research groups.
Our four research groups work together to develop novel drugs